Exploring Hydrophilic PD-L1 Radiotracers Utilizing Phosphonic Acids: Insights into Unforeseen Pharmacokinetics

Immune checkpoint inhibitor therapy targeting the PD-1/PD-L1 axis in cancer patients, is a promising oncological treatment. However, the number of non-responders remains high, causing a burden for the patient and the healthcare system. Consequently, a diagnostic tool to predict treatment outcomes wo...

Descripción completa

Detalles Bibliográficos
Autores principales: Krutzek, Fabian, Donat, Cornelius K., Stadlbauer, Sven
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10606431/
https://www.ncbi.nlm.nih.gov/pubmed/37894769
http://dx.doi.org/10.3390/ijms242015088

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10606431/
https://www.ncbi.nlm.nih.gov/pubmed/37894769
http://dx.doi.org/10.3390/ijms242015088

Ejemplares similares